Takeda Pharmaceutical Company Limited is engaged in the research, development, manufacture and marketing of pharmaceuticals, over-the-counter drugs and quasi-drug consumer products, and other health care products. The company is headquartered in Tokyo, Japan.
Retail traders are piling into Novavax on cancer-vaccine speculation, but the move that actually changed the company's business model happened quietly last week and has nothing to do with oncology.
BioCryst just turned profitable, its HAE drug Orladeyo is minting cash, and a rival's blockbuster acquisition just put the whole rare-disease sector in play. So which pharma giant has the most to…
Friday's top analyst upgrades and downgrades included Adobe, Citigroup, FedEx, Foot Locker, Hewlett Packard Enterprise, Intel, Medical Properties Trust, Nike, Qualcomm, Skyworks Solutions, Takeda Pharmaceutical and Under Armour.
Tuesday's additional top analyst upgrades and downgrades included Apollo Global Management, Cinemark, ConocoPhillips, EOG Resources, Fastly, Southwestern Energy, Sunrun and Takeda Pharmaceutical.
One of Cathie Wood's Ark Invest funds sold nearly 850,000 shares of Takeda Pharmaceutical on December 7.
One of Cathie Wood's Ark Invest funds sold over 690,000 shares of Takeda Pharmaceutical on November 16.
In this massively overbought market, health care stocks could benefit from a shift toward more defensive sectors. These five offer strong balance sheets, attractive dividend yields and improved cost structures, and they…
These four big pharmaceutical stocks are rated Buy by top Wall Street firms and look like very good ideas for investors, especially now that the market is overbought and the slow seasonal…
One of Cathie Wood's Ark Invest funds sold over 350,000 shares of Takeda Pharmaceutical on June 16.
One of Cathie Wood's Ark Invest funds sold over 225,000 shares of Takeda Pharma on June 15.
